Positive News SentimentPositive NewsNASDAQ:CBUS Cibus (CBUS) Stock Price, News & Analysis → Wall Street Legend Warns: 'A Strange Day Is Coming to America' (From Chaikin Analytics) (Ad) Free CBUS Stock Alerts $14.94 -0.60 (-3.86%) (As of 05/28/2024 ET) Add Compare Share Share Today's Range$14.90▼$15.7550-Day Range$14.90▼$22.8252-Week Range$8.90▼$38.85Volume140,665 shsAverage Volume61,649 shsMarket Capitalization$321.96 millionP/E RatioN/ADividend YieldN/APrice Target$25.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Cibus alerts: Email Address Cibus MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside67.3% Upside$25.00 Price TargetShort InterestBearish4.26% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.89Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($3.22) to ($2.35) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.16 out of 5 starsConsumer Staples Sector100th out of 135 stocksAgricultural Chemicals Industry8th out of 9 stocks 3.5 Analyst's Opinion Consensus RatingCibus has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageCibus has only been the subject of 1 research reports in the past 90 days.Read more about Cibus' stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted4.26% of the float of Cibus has been sold short.Short Interest Ratio / Days to CoverCibus has a short interest ratio ("days to cover") of 8.9.Change versus previous monthShort interest in Cibus has recently increased by 31.84%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldCibus does not currently pay a dividend.Dividend GrowthCibus does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CBUS. Previous Next 3.3 News and Social Media Coverage News SentimentCibus has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Cibus this week, compared to 1 article on an average week. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cibus insiders have not sold or bought any company stock.Percentage Held by Insiders49.40% of the stock of Cibus is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 33.81% of the stock of Cibus is held by institutions.Read more about Cibus' insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Cibus are expected to grow in the coming year, from ($3.22) to ($2.35) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cibus is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cibus is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCibus has a P/B Ratio of 1.21. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Cibus' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Chaikin AnalyticsWall Street Legend Warns: "A Strange Day Is Coming to America"Get Your Cash Out of U.S. Banks Immediately Man who predicted 2023 bank run warns a historic financial reset is coming. Get out of cash and into a new vehicle 50 years in the making.Click here to learn more. About Cibus Stock (NASDAQ:CBUS)Cibus, Inc., a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. Cibus, Inc. is based in San Diego, California.Read More CBUS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CBUS Stock News HeadlinesMay 16, 2024 | finance.yahoo.comCibus, Inc. (CBUS)May 15, 2024 | finance.yahoo.comCanada Added to a Growing List of Countries Regulating Cibus’ Gene Editing Technologies Similar to Conventional BreedingMay 15, 2024 | globenewswire.comCanada Added to a Growing List of Countries Regulating Cibus' Gene Editing Technologies Similar to Conventional BreedingMay 13, 2024 | msn.comCibus, Inc. (NASDAQ:CBUS) Q1 2024 Earnings Call TranscriptMay 13, 2024 | finance.yahoo.comCibus to Participate in the BMO Global Farm to Market ConferenceMay 10, 2024 | markets.businessinsider.comCibus’ Promising Developments and Financial Stability Bolster Buy RatingMay 10, 2024 | markets.businessinsider.comCibus Reports Q1 Loss, Tops Revenue EstimatesMay 10, 2024 | investorplace.comCBUS Stock Earnings: Cibus Misses EPS, Beats Revenue for Q1 2024May 9, 2024 | finance.yahoo.comCibus Reports First Quarter Financial Results and Provides Business UpdateMay 5, 2024 | morningstar.comCibus Inc Ordinary Shares - Class A CBUSMay 3, 2024 | finance.yahoo.comCibus, Inc.'s (NASDAQ:CBUS) top owners are individual investors with 53% stake, while 26% is held by institutionsApril 25, 2024 | globenewswire.comCibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference CallMarch 23, 2024 | finance.yahoo.comCibus Full Year 2023 Earnings: Revenues Beat Expectations, EPS LagsMarch 22, 2024 | markets.businessinsider.comCibus’s Market Potential and Advancements Justify Buy RatingMarch 22, 2024 | insidermonkey.comCibus, Inc. (NASDAQ:CBUS) Q4 2023 Earnings Call TranscriptMarch 21, 2024 | investorplace.comCBUS Stock Earnings: Cibus Beats EPS, Beats Revenue for Q4 2023March 21, 2024 | stockhouse.comCibus Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024March 21, 2024 | finance.yahoo.comCibus Inc (CBUS) Reports Q4 Financial Results and Business DevelopmentsMarch 21, 2024 | globenewswire.comCibus Reports Fourth Quarter Financial Results and Provides Business UpdateMarch 19, 2024 | finance.yahoo.comCibus Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2024March 17, 2024 | finance.yahoo.comCBUS May 2024 30.000 callMarch 17, 2024 | finance.yahoo.comCBUS Sep 2024 12.500 putMarch 13, 2024 | globenewswire.comCibus to Participate in the 36th Annual Roth ConferenceMarch 7, 2024 | finance.yahoo.comCibus to Report Fourth Quarter 2023 Financial Results on March 21, 2024 and Host Conference CallFebruary 26, 2024 | globenewswire.comCibus and Loveland Products Collaborate to Develop and Sell Rice Traits in the USSee More Headlines Receive CBUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cibus and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today5/28/2024Next Earnings (Estimated)8/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Agricultural chemicals Sub-IndustryN/A Current SymbolNASDAQ:CBUS CUSIPN/A CIK1705843 Webwww.calyxt.com Phone(858) 450-0008FaxN/AEmployees183Year FoundedN/APrice Target and Rating Average Stock Price Target$25.00 High Stock Price Target$25.00 Low Stock Price Target$25.00 Potential Upside/Downside+60.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($18.35) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-267,640,000.00 Net Margins-12,313.28% Pretax Margin-15,483.06% Return on Equity-23.33% Return on Assets-13.19% Debt Debt-to-Equity RatioN/A Current Ratio1.23 Quick Ratio1.23 Sales & Book Value Annual Sales$1.82 million Price / Sales184.00 Cash Flow$7.73 per share Price / Cash Flow2.01 Book Value$12.38 per share Price / Book1.26Miscellaneous Outstanding Shares21,550,000Free Float10,902,000Market Cap$334.89 million OptionableOptionable Beta1.99 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Rory Balfour Riggs M.B.A. (Age 71)Co-Founder, CEO & Chairman Dr. Peter Beetham B.Sc. (Age 61)Ph.D., Co-Founder, President, COO & Director Dr. Greg Gocal Ph.D. (Age 55)Co-Founder, Chief Scientific Officer & Executive VP Dr. Wade Hampton King (Age 66)Chief Financial Officer Mr. Steve BerrethGeneral Counsel & Corporate SecretaryMs. Rosa Cheuk Kim J.D.Senior Vice President of LegalDr. James Radtke Ph.D.Senior Vice President of Product DevelopmentMr. Tony MoranSenior Vice President of International DevelopmentNorm SissonsSenior Vice President of Seed & TraitsMs. Noel Sauer Ph.D.Senior Vice President of ResearchMore ExecutivesKey CompetitorsMarrone Bio InnovationsNASDAQ:MBIILifeVantageNASDAQ:LFVNNatural Alternatives InternationalNASDAQ:NAIIMannatechNASDAQ:MTEXBioceres Crop SolutionsNASDAQ:BIOXView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 26,017 shares on 5/10/2024Ownership: 3.339%Rory B RiggsBought 517,107 shares on 12/12/2023Total: $5.47 M ($10.58/share)View All Insider TransactionsView All Institutional Transactions CBUS Stock Analysis - Frequently Asked Questions Should I buy or sell Cibus stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cibus in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" CBUS shares. View CBUS analyst ratings or view top-rated stocks. What is Cibus' stock price target for 2024? 1 equities research analysts have issued 1 year target prices for Cibus' stock. Their CBUS share price targets range from $25.00 to $25.00. On average, they expect the company's stock price to reach $25.00 in the next year. This suggests a possible upside of 67.3% from the stock's current price. View analysts price targets for CBUS or view top-rated stocks among Wall Street analysts. How have CBUS shares performed in 2024? Cibus' stock was trading at $19.64 on January 1st, 2024. Since then, CBUS stock has decreased by 23.9% and is now trading at $14.94. View the best growth stocks for 2024 here. Are investors shorting Cibus? Cibus saw a increase in short interest in May. As of May 15th, there was short interest totaling 610,400 shares, an increase of 31.8% from the April 30th total of 463,000 shares. Based on an average daily volume of 68,800 shares, the short-interest ratio is presently 8.9 days. Currently, 4.3% of the company's stock are short sold. View Cibus' Short Interest. When is Cibus' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024. View our CBUS earnings forecast. How were Cibus' earnings last quarter? Cibus, Inc. (NASDAQ:CBUS) issued its quarterly earnings data on Thursday, May, 9th. The company reported ($1.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.01) by $0.11. The firm had revenue of $0.55 million for the quarter, compared to analysts' expectations of $0.40 million. Cibus had a negative net margin of 12,313.28% and a negative trailing twelve-month return on equity of 23.33%. During the same quarter in the prior year, the business earned ($5.45) earnings per share. When did Cibus IPO? Cibus (CBUS) raised $100 million in an initial public offering (IPO) on Thursday, February 14th 2019. The company issued 6,700,000 shares at $14.00-$16.00 per share. Morgan Stanley, BofA Merrill Lynch and Piper Jaffray acted as the underwriters for the IPO. Who are Cibus' major shareholders? Cibus' stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (3.34%). View institutional ownership trends. How do I buy shares of Cibus? Shares of CBUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CBUS) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy SykesElon’s New Device is About to Shock the WorldInvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for AIWeiss RatingsThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDigitizing the $11T commodities sector with one tiny stockResource Stock DigestMusk, Bezos, and Gates All On Board… Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cibus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
